UCSF

ZINC04099009

Substance Information

In ZINC since Heavy atoms Benign functionality
November 7th, 2005 46 No

CAS Number: 29767-20-2

Other Names:

(10R,11R,15R,16S)-16-{[(4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-(thiophen-2-yl)-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one

(5R-(5alpha,5abeta,8aalpha,9beta(R*)))-5,8,8a,9-Tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4-6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one; 4'-Demethyl 1-O-(4,6-O,O-(2-thenylidene)-beta-D-gluc

23362-13-2

29767-20-2

29767-20-2; C11153; Teniposide; VM-26

29767-20-2; D02698; Teniposide (USAN/INN); Vumon (TN)

299-36-5

31514-29-1

35317-44-3

4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin-beta-D-thenylidene glucoside; HSDB 6546; NSC 122819; NSC-122819

4'-Demethylepipodophyllotoxin thenylidene glucoside

4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside

4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin

4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside

55256-09-2

AC-759

AC1L1K9H

AC1L1S3X

AC1L32H7

AC1L5IF3

AC1L9QDK

AC1NR4S8

AC1O8FOE

Ambap29767-20-2

AR-1A6252

AR-1A6526

BAN

BRD-A35588707-001-02-2

BSPBio_003436

C11153

C32H32O13S

CCRIS 2058

CHEBI:9917

CHEMBL278534

CID107642

CID275784

CID34698

CID452548

CID5284623

CID5396

CID6708778

D02698

DAP000651

DB00444

Demethyl Epipodophyllotoxin Thenylidine Glucoside

DivK1c_006888

EINECS 249-831-2

Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside)

Epipodophyllotoxin-beta-D-thenylidene-glucoside, 4'-demethyl-

FDA

FT-0080118

HMS1922B15

HMS2093O15

HSDB 6546

I06-2040

INN

KBio1_001832

KBio2_002029

KBio2_004597

KBio2_007165

KBio3_002939

KBioGR_001050

KBioSS_002029

KST-1A3576

KST-1A5976

LS-63999

MFCD00866516

MLS000766234

MolPort-003-666-525

MolPort-005-940-276

MolPort-006-822-656

NCI60_000540

Neuro_000056

NSC 122819

NSC 12819

NSC-122819

NSC122819

PTG

S1787_Selleck

SMR000528847

SPBio_001773

SpecPlus_000792

SPECTRUM1504094

Spectrum2_001647

Spectrum3_001898

Spectrum4_000585

Spectrum5_001111

Spectrum_001549

Teniposide (BAN

Teniposide (FDA

Teniposide (USAN/INN)

Teniposide [USAN:BAN:INN]

teniposide; teniposido; teniposidum

Teniposido

Teniposido [INN-Spanish]

Teniposido [INN-Spanish];Teniposidum [INN-Latin]

Teniposidum

Teniposidum [INN-Latin]

UNII-957E6438QA

USAN)

Vee M-26

Veham-Sandoz

Vehem

VM 26

VM-26

Vumon

Vumon (TN)

Vumon, VM-26, Vehem, NSC 122819, Teniposide

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 1.81 -8.39 -20.43 3 13 0 160 656.662 6

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 5.98e-02 g/l DrugBank-approved
Indications acute lymphocytic leukemia KeyOrganics Bioactives
PUBCHEM_PATENT_ID EP0007597A1; EP0110955A1; EP0110955B1; EP0120907A1; EP0185740A1; EP0226202A2; EP0226202B1; EP0261174A1; EP0270340A2; EP0270340B1; EP0289030A2; EP0291957A2; EP0292710A2; EP0292710B1; EP0297594A2; EP0302473A2; EP0302473B1; EP0304086A2; EP0304086B1; EP030597 IBM Patent Data

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.